ATG9A Protein

ATG9A Protein — Autophagy-Related Protein 9A

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="text-align:center;">ATG9A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Autophagy-related protein 9A</td></tr>
<tr><td><strong>Encoded by</strong></td><td>[ATG9A](/genes/atg9a)</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q7Z418](https://www.uniprot.org/uniprotkb/Q7Z418/entry)</td></tr>
<tr><td><strong>Localization</strong></td><td>Trans-Golgi network, endosomes, plasma membrane, autophagosomes</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Multi-pass transmembrane autophagy protein</td></tr>
<tr><td><strong>Major Pathway</strong></td><td>[Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">161 edges</a></td>
</tr>
</table>
</div>

Overview

ATG9A Protein — Autophagy-Related Protein 9A

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="text-align:center;">ATG9A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Autophagy-related protein 9A</td></tr>
<tr><td><strong>Encoded by</strong></td><td>[ATG9A](/genes/atg9a)</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q7Z418](https://www.uniprot.org/uniprotkb/Q7Z418/entry)</td></tr>
<tr><td><strong>Localization</strong></td><td>Trans-Golgi network, endosomes, plasma membrane, autophagosomes</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Multi-pass transmembrane autophagy protein</td></tr>
<tr><td><strong>Major Pathway</strong></td><td>[Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">161 edges</a></td>
</tr>
</table>
</div>

Overview

ATG9A (Autophagy-Related Protein 9A) is the only multi-spanning transmembrane protein in the core autophagy machinery, playing an essential role in autophagosome biogenesis by providing membrane lipids and serving as a membrane source for phagophore expansion. Unlike other ATG proteins that are soluble or peripherally associated with membranes, ATG9A is an integral membrane protein that spans the membrane multiple times, uniquely positioning it to serve as a membrane source for autophagosome formation[@atga2012][@autophagia2014].

The protein cycles between different cellular compartments in a process tightly regulated by the autophagy initiation machinery. During starvation-induced autophagy, ATG9A-containing vesicles are actively recruited to the phagophore assembly site (PAS), where they contribute their membrane to the growing phagophore. This function makes ATG9A essential for autophagosome nucleation and expansion, with knockout or knockdown of ATG9A severely impairing autophagy and leading to accumulation of protein aggregates and damaged organelles[@atg9a2015].

In the nervous system, ATG9A is critical for neuronal homeostasis, as autophagy is essential for clearing misfolded proteins, damaged mitochondria, and other cellular debris. Dysregulation of ATG9A-mediated autophagy has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis[@neurodegener2016][@tau2019].

Domain Architecture and Molecular Structure

Primary Structure

ATG9A is a 939-amino acid protein with multiple transmembrane domains:

• N-terminal Cytoplasmic Domain (1-200 aa): Contains sorting signals (YXXΦ motifs) and ATG2 interaction motifs that mediate recruitment to autophagy initiation sites.
• Transmembrane Regions (200-700 aa): Multiple transmembrane segments (typically 12-15) that anchor the protein in membrane compartments. These regions form the core of the protein and are highly conserved.
• C-terminal Cytoplasmic Domain (700-939 aa): Contains regulatory sites including phosphorylation residues and additional sorting signals. This region modulates protein localization and interactions.

Structure-Function Relationships

The structure of ATG9A (PDB: 6J5N) reveals a unique fold that allows it to:

• Interact with lipid bilayers and deform membranes
• Bind to other autophagy proteins including ATG2 and WIPI proteins
• Cycle between different cellular compartments
• Form oligomers that may facilitate membrane transfer

Normal Cellular Functions

Autophagosome Biogenesis

ATG9A plays multiple essential roles in autophagosome formation[@atg9a2015]:

Membrane Trafficking

ATG9A participates in membrane trafficking pathways:

• Trans-Golgi Network Dynamics: ATG9A cycles through the TGN, contributing membrane to various cellular compartments.
• Endosomal Function: ATG9A localizes to endosomes and participates in endosomal maturation.
• Plasma Membrane Recycling: ATG9A can be found at the plasma membrane, where it may be internalized during autophagy initiation.

Autophagy Regulation

ATG9A is regulated at multiple levels:

• Phosphorylation: ULK1 phosphorylates ATG9A during autophagy initiation, promoting its recruitment to the PAS.
• Lipid Binding: Interactions with phosphoinositides regulate membrane targeting.
• Protein Interactions: ATG2, WIPI proteins, and other ATG proteins regulate ATG9A function.

Role in Neurodegenerative Diseases

Alzheimer's Disease

ATG9A dysfunction contributes to AD pathogenesis through multiple mechanisms[@tang2021][@neurodegener2016]:

Parkinson's Disease

ATG9A is critical in PD through several mechanisms[@alpha2017][@mitophagy2018]:

Amyotrophic Lateral Sclerosis

In ALS:

• Protein Aggregate Clearance: ATG9A-mediated autophagy clears TDP-43 aggregates, a hallmark of ALS pathology.
• Motor Neuron Survival: ATG9A is critical for motor neuron health, with deficiency leading to progressive motor neuron degeneration.
• Axonal Homeostasis: ATG9A maintains axonal integrity through autophagy-mediated clearance of axonal debris.
• ER Stress: ATG9A dysfunction contributes to ER stress, a common feature of ALS pathogenesis[@liu2022].

Huntington's Disease

In HD:

• Mutant Huntingtin Clearance: Autophagy clears toxic huntingtin protein aggregates. ATG9A deficiency leads to accumulation of mutant huntingtin.
• Neuronal Dysfunction: Loss of ATG9A function exacerbates pathology and accelerates disease progression.
• Vesicle Trafficking: Altered membrane dynamics affect neuronal function.

Therapeutic Approaches

Current Strategies

Research Directions

• ATG9A Modulation: Developing drugs that enhance ATG9A function
• Protein-Protein Interaction Modulators: Targeting the ATG2-ATG9A interaction
• Combination Therapies: Autophagy enhancement with anti-aggregation agents
• Biomarkers: ATG9A expression as a therapeutic response marker

Challenges

• BBB Delivery: Therapeutic delivery to the CNS is challenging
• Autophagy Balance: Chronic overactivation may be detrimental
• Timing: Intervention timing may be critical for efficacy

Interactions with Other Proteins

ATG9A interacts with key autophagy proteins:

| Protein | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| ATG2A/B | Direct binding | Lipid transfer from ER |
| WIPI1/2/3/4 | Indirect | Phosphatidylinositol 3-phosphate binding |
| ULK1/2 Complex | Direct | Phosphorylation and recruitment |
| ATG14L | Indirect | Autophagosome targeting |
| VPS34/PIK3C3 | Indirect | Lipid kinase complex |
| ATG5 | Indirect | Autophagy conjugation system |
| ATG7 | Indirect | LC3 activation |

Neuropathology

Brain Regions Affected

• Hippocampus: CA1 neurons affected in AD
• Substantia Nigra: Dopaminergic neuron loss in PD
• Motor Cortex: Upper motor neuron loss in ALS
• Cerebellum: Less commonly affected
• Peripheral Nerves: Axonal degeneration in peripheral neuropathy

Pathological Features

• Protein Inclusions: Accumulation of ubiquitinated protein aggregates
• Autophagosome Accumulation: Impaired autophagy leads to buildup of autophagic structures
• Lysosomal Dysfunction: Accumulation of lipofuscin and other lysosomal debris
• Neuronal Loss: Progressive degeneration of specific populations

See Also

• [ATG9A Gene](/genes/atg9a)
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Alpha-Synuclein Aggregation Pathway](/mechanisms/alpha-synuclein-aggregation-pathway)
• [Tau Pathology](/mechanisms/tau-pathway)
• [Mitophagy](/mechanisms/mitophagy-pathway)

External Links

• [UniProt: ATG9A](https://www.uniprot.org/uniprotkb/Q7Z418/entry)
• [NCBI Gene: ATG9A](https://www.ncbi.nlm.nih.gov/gene/57409)
• [AlphaFold Structure](https://alphafold.ebi.ac.uk/entry/Q7Z418)
• [PDB: 6J5N](https://www.rcsb.org/structure/6J5N)

References